| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |